Nuwellis PE Ratio 2011-2024 | NUWE
Current and historical p/e ratio for Nuwellis (NUWE) from 2011 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nuwellis PE ratio as of December 11, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Nuwellis PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-12-11 | 1.30 | 0.00 | |
| 2024-09-30 | 1.19 | $-116.41 | 0.00 |
| 2024-06-30 | 5.03 | $-181.44 | 0.00 |
| 2024-03-31 | 12.44 | $-290.21 | 0.00 |
| 2023-12-31 | 20.33 | $-470.63 | 0.00 |
| 2023-09-30 | 50.05 | $-567.13 | 0.00 |
| 2023-06-30 | 94.15 | $-1,797.55 | 0.00 |
| 2023-03-31 | 170.10 | $-3,103.50 | 0.00 |
| 2022-12-31 | 375.20 | $-4,370.63 | 0.00 |
| 2022-09-30 | 1887.55 | $-5,629.37 | 0.00 |
| 2022-06-30 | 2061.15 | $-6,958.04 | 0.00 |
| 2022-03-31 | 3535.00 | $-8,041.96 | 0.00 |
| 2021-12-31 | 3990.00 | $-10,944.06 | 0.00 |
| 2021-09-30 | 7700.00 | $-13,461.54 | 0.00 |
| 2021-06-30 | 14700.00 | $-18,111.89 | 0.00 |
| 2021-03-31 | 20685.00 | $-26,094.42 | 0.00 |
| 2020-12-31 | 24395.00 | $-60,573.83 | 0.00 |
| 2020-09-30 | 30607.50 | $-174,222.88 | 0.00 |
| 2020-06-30 | 50274.00 | $-345,450.35 | 0.00 |
| 2020-03-31 | 46200.00 | $-537,600.54 | 0.00 |
| 2019-12-31 | 90425.99 | $-1,703,101.50 | 0.00 |
| 2019-09-30 | 157499.99 | $-2,464,352.30 | 0.00 |
| 2019-06-30 | 305549.98 | $-3,182,911.80 | 0.00 |
| 2019-03-31 | 431549.97 | $-4,568,498.60 | 0.00 |
| 2018-12-31 | 717653.92 | $-18,070,047.60 | 0.00 |
| 2018-09-30 | 1734599.80 | $-23,882,380.70 | 0.00 |
| 2018-03-31 | 4101299.53 | $-36,808,861.00 | 0.00 |
| 2017-12-31 | 5086199.42 | $-86,691,264.00 | 0.00 |
| 2017-09-30 | 17231338.02 | $-208,456,064.00 | 0.00 |
| 2017-06-30 | 30281996.52 | $-203,132,528.00 | 0.00 |
| 2017-03-31 | 53507993.85 | $-427,782,988.00 | 0.00 |
| 2016-12-31 | 100000000.00 | $-579,456,848.00 | 0.00 |
| 2018-06-30 | 2704799.69 | $-672,627,748.00 | 0.00 |
| 2016-09-30 | 100000000.00 | $-989,225,400.00 | 0.00 |
| 2016-06-30 | 100000000.00 | $-1,068,716,700.00 | 0.00 |
| 2016-03-31 | 100000000.00 | $-1,174,705,100.00 | 0.00 |
| 2015-12-31 | 100000000.00 | $-1,298,358,300.00 | 0.00 |
| 2015-09-30 | 100000000.00 | $-1,333,687,800.00 | 0.00 |
| 2015-06-30 | 100000000.00 | $-1,333,687,800.00 | 0.00 |
| 2015-03-31 | 100000000.00 | $-1,360,185,000.00 | 0.00 |
| 2014-12-31 | 100000000.00 | $-1,342,520,300.00 | 0.00 |
| 2014-09-30 | 100000000.00 | $-1,360,185,000.00 | 0.00 |
| 2014-06-30 | 100000000.00 | $-1,457,341,100.00 | 0.00 |
| 2014-03-31 | 100000000.00 | $-1,430,843,900.00 | 0.00 |
| 2013-12-31 | 100000000.00 | $-1,510,335,200.00 | 0.00 |
| 2013-09-30 | 100000000.00 | $-1,528,000,000.00 | 0.00 |
| 2013-06-30 | 100000000.00 | $-1,483,838,100.00 | 0.00 |
| 2013-03-31 | 100000000.00 | $-1,545,664,700.00 | 0.00 |
| 2012-12-31 | 100000000.00 | $-1,713,479,700.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.006B | $0.009B |
| Nuwellis Inc. is a medical device company. It is focused on developing, manufacturing and commercializing the Aquadex SmartFlow(R) System for ultrafiltration therapy. Nuwellis Inc., formerly known as CHF Solutions, is headquartered in Minneapolis, Minn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.393B | 24.93 |
| Intuitive Surgical (ISRG) | United States | $193.619B | 101.23 |
| Edwards Lifesciences (EW) | United States | $43.533B | 27.64 |
| Alcon (ALC) | Switzerland | $42.700B | 28.57 |
| IQVIA Holdings (IQV) | United States | $36.494B | 20.11 |
| IDEXX Laboratories (IDXX) | United States | $35.790B | 42.15 |
| DexCom (DXCM) | United States | $31.431B | 47.33 |
| Waters (WAT) | United States | $22.876B | 33.83 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.760B | 0.00 |
| Hologic (HOLX) | United States | $17.141B | 18.51 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.008B | 14.38 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.294B | 28.60 |
| Penumbra (PEN) | United States | $9.735B | 95.36 |
| Masimo (MASI) | United States | $9.336B | 45.18 |
| Teleflex (TFX) | United States | $8.528B | 13.60 |
| Glaukos (GKOS) | United States | $7.879B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.728B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.717B | 26.73 |
| Inari Medical (NARI) | United States | $3.408B | 0.00 |
| Veracyte (VCYT) | United States | $3.372B | 101.19 |
| LivaNova (LIVN) | United Kingdom | $2.796B | 16.14 |
| Nihon Kohden (NHNKY) | Japan | $2.337B | 17.75 |
| Tandem Diabetes Care (TNDM) | United States | $2.267B | 0.00 |
| TransMedics (TMDX) | United States | $2.261B | 71.66 |
| Elekta AB (EKTAY) | Sweden | $2.229B | 20.04 |
| Integra LifeSciences Holdings (IART) | United States | $1.864B | 9.74 |
| RxSight (RXST) | United States | $1.515B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.254B | 83.11 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.062B | 0.00 |
| Paragon 28 (FNA) | United States | $0.874B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.859B | 14.60 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.708B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.699B | 16.49 |
| IRadimed (IRMD) | United States | $0.699B | 37.80 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.622B | 0.00 |
| SiBone (SIBN) | United States | $0.580B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.558B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.535B | 31.48 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.453B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.440B | 23.83 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.331B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.230B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.198B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.177B | 0.00 |
| Nevro (NVRO) | United States | $0.162B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.12 |
| Spectral Diagnostics (EDTXF) | Canada | $0.104B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.011B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |